Body Compartment Pharmacokinetics of Anti-retroviral Agents That May be Used for Future HIV Post-exposure Prophylaxis Regimens.
Phase of Trial: Phase I
Latest Information Update: 10 May 2018
At a glance
- Drugs Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary) ; Darunavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms PEP2
- 18 Apr 2018 Status changed from not yet recruiting to recruiting.
- 27 Mar 2018 New trial record